To explore the potential clinical value of FIGNL1, we again used GEPIA and Kaplan-Meier Plotter databases to analyze the correlation between FIGNL1 expression levels and overall survival, progression-free survival, and clinical stage of HCC patients. This evidence concerns the gene FIGNL1 and hepatocellular carcinoma.